Aug 2026· Discover Life· Vol 56· 0 citations· 108 references
TL;DR
The computationally designed vaccine meets all essential criteria and has shown immense potential to be an effective vaccine through in silico analysis, however, additional In-vitro and In-vivo validations are imperative.
Abstract
Livestock production is a major contributor to food security and livelihoods worldwide. Among the parasitic diseases affecting livestock, Taenia solium infection remains a significant veterinary and public health concern, causing substantial economic losses. Therefore, effective and affordable vaccine development is required for disease prevention and improved livestock health. A multi-epitopic chimeric vaccine for livestock against Taenia spp. was computationally designed using subtractive proteomics and immuno-informatics. Antigenic proteins were selected based on antigenicity, allergenicity, and physicochemical profiling. HTL, CTL, and B-cell epitopes were predicted and assembled into a chimeric structure along with a suitable adjuvant. Structure modeling and physical characteristics, such as docking tendency with TLRs, along with the immune stimulatory response, were analysed. Molecular dynamics simulations for the TLR4-Vaccine complexes were also done for 100 ns. Immune simulation and codon optimisation predicted immunogenicity and expression potential in E. coli. 11 epitopes were identified from 3 antigenic homologous proteins. A multiepitope chimeric vaccine was designed by adding β-defensin adjuvant to mount a robust immune response. The proposed vaccine construct had 272 Amino acid residues and a molecular weight of 28.94 kDa. Upon binding with TLR4 receptors, it establishes a stable conformation, and molecular dynamics simulations also demonstrated a dynamic interplay. A multi-epitope vaccine capable of disrupting the life cycle of Taenia species across all known hosts was designed. The computationally designed vaccine meets all essential criteria and has shown immense potential to be an effective vaccine through in silico analysis. However, additional In-vitro and In-vivo validations are imperative.
The rationally designed multi-epitope vaccine demonstrates robust theoretical potential to elicit comprehensive, long-lasting immunity in humans, although its safety and effectiveness require additional experimental validation.
Chenchen Yi, Yu Shen, Ye Luo et al.· Frontiers in Cellular and In...· 0 citations
Vc7 has been identified as a structurally stable and highly immunogenic construct, suggesting its potential as a universal multi-epitope vaccine candidate for the prevention of brucellosis.
Rhitam Biswas, Swapno Surabhi Sinha, Aditi Roy et al.· Frontiers in Bioinformatics· 0 citations
This study demonstrates an immunoinformatics-guided multi-epitope vaccine strategy against T. gondii, supported by in vivo immunogenicity and partial protective efficacy in a mouse model.
Wen-Yong Feng, Lu Sun, Cheng-Long Yang et al.· Frontiers in Immunology· 0 citations
The proposed multi-epitope vaccine shows promising immunological and structural properties, supporting its potential against S. typhimurium, pending experimental validation.
Mohammed Naveez Valathoor, A. P. Rajan· Scientific Reports· 0 citations
The results highlight the potential of the proposed multi-epitope construct as a promising vaccine candidate against HCMV, however, experimental validation is essential to confirm its immunogenicity, safety, and translational applicability.
O. P. Emmanuel, M. N. Y. Sandrine, Bilanda Danielle Claude et al.· Scientific Reports· 0 citations
The current study suggests a rationally engineered multi-epitope bivalent vaccine candidate against P. vivax, providing a base for future experimental validation.
Muharib Alruwaili, Intisar Alruwaili, Bayan Fallatah et al.· BMC Microbiology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.